An intelligent biomimetic Janus nanomotor featuring a built‐in “electronic lock” for spatiotemporally controlled on‐demand therapy establishes a highly promising translational paradigm for combating deep‐seated and multidrug‐resistant bacterial infections.
Abstract
Bacterial pneumonia treatment is severely hampered by escalating antibiotic resistance and physiological drug delivery barriers. To address these critical challenges, we report the development of an intelligent biomimetic Janus nanomotor (MAgAu@CM) featuring a built‐in “electronic lock” for spatiotemporally controlled on‐demand therapy. The nanomotor is constructed from a melanin‐supported AgAu alloy and camouflaged with an erythrocyte and platelet hybrid membrane, ensuring prolonged systemic circulation and active inflammation targeting. Crucially, the potent silver component remains therapeutically inert during circulation due to a highly stable electronic compensation mechanism. Upon near‐infrared irradiation at the target infection site, the localized photothermal effect acts as a specific “key.” This thermal intervention not only provides direct hyperthermic ablation of the pathogens but also disrupts the electronic equilibrium, triggering the burst release of bactericidal Ag
+
for powerful synergistic chemo‐photothermal eradication. Concurrently, this photothermal input overclocks the inherent nanozyme activity of the nanomotor, catalyzing the decomposition of endogenous H
2
O
2
to generate robust oxygen‐driven mechanical propulsion for deep penetration into complex infectious biofilms. Furthermore, this system actively remodels the hostile pathological microenvironment by alleviating local hypoxia and promoting the functional polarization of macrophages toward a tissue‐repairing M2 phenotype. By integrating biomimetic stealth, active navigation, stimuli‐responsive propulsion, and microenvironment remodeling, this multifunctional nanoplatform establishes a highly promising translational paradigm for combating deep‐seated and multidrug‐resistant bacterial infections.
ABSTRACT Sepsis remains a leading cause of mortality because current therapies fail to address its dynamically evolving pathophysiology, in which infection, oxidative stress, and immune dysfunction emerge sequentially and interdependently. Here, we present a pH‐adaptive nanozyme platform (MICP@HG) that orchestrates sta...
An-Lai Zou, Xiao-Xue Zhu, Run-Han Zhu et al.· Advancement of science· 0 citations
ABSTRACT Bacterial pneumonia treatment faces significant challenges due to uncontrolled inflammation and rising antibiotic resistance. Excessive inflammatory cytokine release and mitochondrial dysfunction exacerbate tissue damage, contributing to the disease's progression. Mitophagy, a process that eliminates dysfuncti...
Xiao-Feng Luo, Yun-Di Wu, Shuai Zhang et al.· Advancement of science· 0 citations
Fungal infections represent a significant global health threat, exacerbated by the scarcity of new therapeutic options, increasing drug resistance, and host toxicity. Sonodynamic therapy (SDT) offers a promising approach to overcoming antimicrobial resistance by enabling the localized generation of cytotoxic reactive o...
Qian Li, Yi-Da Pang, Jun-Hua Zhang et al.· Journal of the American Chem...· 0 citations
The intratumoral microbiota acts as a microbial immune checkpoint in colorectal cancer (CRC), yet current strategies either kill silently without immune activation or permit bacterial rebound through incomplete targeting. Here we report a bio-hybrid assembly designed to synchronize the eradication of CRC cells and thei...
Maliang Tao, Bin-Bin Wei, Yen-Yu Yang et al.· Advances in Materials· 0 citations
Successful long-term bone repair requires implant interfaces to precisely regulate the competitive recruitment between pathogens and host cells. However, coordinating the transition from potent pathogen clearance to refined osteogenic induction remains challenging, as the high-affinity synergies required for rapid bact...
Shi-Jie Shi, Yang Liu, Ming-Yue Han et al.· Biomaterials· 0 citations
An integrated therapeutic framework that combines host-directed redox modulation, bacterial ROS sensitization, and engineered intelligent biomaterials is presented, which offers a versatile and translatable platform for the development of next-generation anti-infective therapies.